Schulz Fran
- SEC CIK
- 0002046804
In the past year, 1 open-market purchase filing worth $47.5K and no sales.
Current role at each company
- FOCL Edap TMS SADirectoras of Aug 17, 2026
- SNTI Senti Biosciences Holdings, Inc.Directoras of Jun 27, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $47.5K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$47.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Schulz Fran as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FOCL Edap TMS SA
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 (view filing)6:04 AM ET | Aug 14 | 3 days | Schulz FranDirector | PPurchase | +10.0K | $4.75 | +$47.5K | +196.1%15.1K after |